PL334770A1 - Quinoxalines in triple combination with inhibitors of protease and inhibitors of reverse transcriptase as an aids treating drug - Google Patents

Quinoxalines in triple combination with inhibitors of protease and inhibitors of reverse transcriptase as an aids treating drug

Info

Publication number
PL334770A1
PL334770A1 PL98334770A PL33477098A PL334770A1 PL 334770 A1 PL334770 A1 PL 334770A1 PL 98334770 A PL98334770 A PL 98334770A PL 33477098 A PL33477098 A PL 33477098A PL 334770 A1 PL334770 A1 PL 334770A1
Authority
PL
Poland
Prior art keywords
inhibitors
quinoxalines
protease
reverse transcriptase
triple combination
Prior art date
Application number
PL98334770A
Other languages
English (en)
Inventor
Arnold Paessens
Martin Blunck
Guenter Riess
Joerg-Peter Kleim
Manfred Roesner
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PL334770A1 publication Critical patent/PL334770A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL98334770A 1997-01-29 1998-01-15 Quinoxalines in triple combination with inhibitors of protease and inhibitors of reverse transcriptase as an aids treating drug PL334770A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19703131A DE19703131A1 (de) 1997-01-29 1997-01-29 Verwendung von Chinoxalin in Dreier-Kombination mit Protease-Inhibitoren und Reverse Transkriptaseinhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen
PCT/EP1998/000197 WO1998032442A1 (de) 1997-01-29 1998-01-15 Chinoxaline in dreier-kombination mit proteaseinhibitoren und reverse transkriptaseinhibitoren als arzneimittel zur behandlung von aids

Publications (1)

Publication Number Publication Date
PL334770A1 true PL334770A1 (en) 2000-03-13

Family

ID=7818634

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98334770A PL334770A1 (en) 1997-01-29 1998-01-15 Quinoxalines in triple combination with inhibitors of protease and inhibitors of reverse transcriptase as an aids treating drug

Country Status (16)

Country Link
EP (1) EP0977570A1 (id)
JP (1) JP2001511124A (id)
KR (1) KR20000070543A (id)
CN (1) CN1251525A (id)
AR (1) AR011094A1 (id)
AU (1) AU6094098A (id)
BR (1) BR9807523A (id)
CA (1) CA2278773A1 (id)
DE (1) DE19703131A1 (id)
ID (1) ID22414A (id)
IL (1) IL130877A0 (id)
NO (1) NO993670L (id)
PL (1) PL334770A1 (id)
SK (1) SK99899A3 (id)
WO (1) WO1998032442A1 (id)
ZA (1) ZA98679B (id)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999060988A2 (en) * 1998-05-29 1999-12-02 University Of Florida Combination therapy for treatment of fiv infection
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
GB9821000D0 (en) * 1998-09-28 1998-11-18 Glaxo Group Ltd Antiviral combinations
AU6329599A (en) * 1998-09-28 2000-04-17 Glaxo Group Limited Antiviral combinations comprising (s)-2-ethyl -7-fluoro -3-oxo-3, 4-dihydro -2h-quinoxaline -1-carboxylic acid isopropyl ester
GB9911887D0 (en) * 1999-05-21 1999-07-21 Glaxo Group Ltd Methods and medicaments for post exposure prophylaxis of an hiv infection
SE9902987D0 (sv) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
CO5300399A1 (es) 2000-02-25 2003-07-31 Astrazeneca Ab Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen
US7005439B2 (en) 2000-06-20 2006-02-28 Astrazeneca Ab Compounds
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
GB0104050D0 (en) 2001-02-19 2001-04-04 Astrazeneca Ab Chemical compounds
AR035230A1 (es) 2001-03-19 2004-05-05 Astrazeneca Ab Compuestos de bencimidazol, proceso para su preparacion, composicion farmaceutica, proceso para la preparacion de dicha composicion farmaceutica, y usos de estos compuestos para la elaboracion de medicamentos
GB0107228D0 (en) 2001-03-22 2001-05-16 Astrazeneca Ab Chemical compounds
SE0101038D0 (sv) 2001-03-23 2001-03-23 Astrazeneca Ab Novel compounds
SE0103818D0 (sv) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
SE0301369D0 (sv) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds
US7351709B2 (en) 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt
CA2633400A1 (en) * 2005-12-15 2007-06-21 Bayer Healthcare Ag Diaryl urea for treating virus infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59209965D1 (de) * 1991-04-15 2002-10-17 Aventis Pharma Gmbh Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung
DE4342024A1 (de) * 1993-12-09 1995-06-14 Hoechst Ag Kombinationspräparate, enthaltend ein Chinoxalin und ein Nukleosid
DE19506742A1 (de) * 1995-02-27 1996-08-29 Bayer Ag Verwendung von Chinoxalinen in Kombination mit Protease-Inhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen

Also Published As

Publication number Publication date
CN1251525A (zh) 2000-04-26
BR9807523A (pt) 2000-03-21
CA2278773A1 (en) 1998-07-30
EP0977570A1 (de) 2000-02-09
AU6094098A (en) 1998-08-18
WO1998032442A1 (de) 1998-07-30
JP2001511124A (ja) 2001-08-07
NO993670D0 (no) 1999-07-28
SK99899A3 (en) 2000-03-13
ID22414A (id) 1999-10-14
AR011094A1 (es) 2000-08-02
NO993670L (no) 1999-09-10
ZA98679B (en) 1998-08-05
KR20000070543A (ko) 2000-11-25
IL130877A0 (en) 2001-01-28
DE19703131A1 (de) 1998-07-30

Similar Documents

Publication Publication Date Title
PL334770A1 (en) Quinoxalines in triple combination with inhibitors of protease and inhibitors of reverse transcriptase as an aids treating drug
PL333505A1 (en) Benzamido-aldehydes and their application as inhibitors of cysteinic proteases
AU4217499A (en) Composition having therapeutic and/or nutritionally active substituent
PL340736A1 (en) Drug in the form of soft granules and method of obtaining same
MXPA99002203A (es) Nuevos derivados de acetamida e inhibidores de proteasa.
AU2002223599A1 (en) Pyrimidinone derivatives and their use in the treatment of atherosclerosis
HUP0102543A3 (en) Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction and medicaments containing them
IL144294A0 (en) P53 inhibitors and therapeutic use of the same
PL333434A1 (en) Aminoguanidines and alkoxyguanidines as inhibitors of proteases
AU4289100A (en) Dihydropyrimidines and their use in the treatment of hepatitis
ATE234840T1 (de) 1-aminotriazolo 4,3-a chinazolin-5-one und/oder - thione inhibitoren von phosphodiesterasen iv
AU5127098A (en) Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis
ZA961516B (en) Use of quinoxalines in combination with protease inhibitors as medicament for treatis aids and/or hiv infections
GB2314273B (en) The use of TCET in the prophylaxis and treatment of allergies
AU2002241661A1 (en) Multifunctional protease inhibitors and their use in treatment of disease
AU5754701A (en) Method of using cox-2 inhibitors in the treatment and prevention of ocular cox-2mediated disorders
PL352333A1 (en) Dihydrobenzodiazepines and use of same in treatment of dislipidemia
AU6536200A (en) Proteases and protease inhibitors
GB9409336D0 (en) Use of an enzyme for manufacturing an agent for the treatment and/or prophylaxis of coccidiosis
AU2001234962A1 (en) Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
PL337577A1 (en) Treatment of diabetes with thiazolydinone and alpha - glucosidaze inhibitor
AU7688998A (en) Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema
AU1430099A (en) Use of galanthamine and galanthamine derivatives in the case of acute functionalbrain damage
AP2000001950A0 (en) Paroxetine maleate.
IL134662A0 (en) Bisethers of 1-oxa, aza and thianaphthalen-2- ones as phospholamban inhibitors